Data / Form D filings / Sorbent Therapeutics Inc
Sorbent Therapeutics Inc: Form D filings
Sorbent Therapeutics Inc, a pharmaceuticals company in Sunnyvale, CA, filed 5 Form D notices with the SEC between 2010 and 2014. The latest, on May 15, 2014, reports $6.5 million sold of a $15 million offering to 10 investors.
Find out what Sorbent Therapeutics Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 710 LAKEWAY DRIVE, SUITE 290, Sunnyvale, CA, 94085
- Phone
- (408) 738-8240
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1352145
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2014 | New notice | $15,000,000 | $6,500,000 | $8,500,000 | 10 | Apr 30, 2014 | sec.gov |
| Aug 8, 2012 | New notice | $24,056,217 | $18,056,217 | $6,000,000 | 10 | Jul 27, 2012 | sec.gov |
| Jun 8, 2012 | New notice | $6,000,000 | $6,000,000 | $0 | 10 | May 31, 2012 | sec.gov |
| Jun 16, 2011 | New notice | $36,000,000 | $11,234,761 | $24,765,239 | 10 | Jun 14, 2011 | sec.gov |
| Jul 14, 2010 | New notice | $21,813,149 | $16,813,149 | $5,000,000 | 10 | Jun 30, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Howard C. Dittrich | Executive Officer | |
| Randall Woods | Director | |
| Jason P. Levin | Executive Officer | |
| Donald Joseph | Director | |
| David Collier | Director | |
| Marcus Goebel | Director | |
| Scott Minick | Director | |
| James Healy | Director | |
| Thomas P. O'Neil | Executive Officer | |
| Linda C. De Young | Executive Officer | |
| Detlef Albrecht | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of May 12, 2014 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sorbent Therapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.